Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach. - Wikidata - wikimedia - TriplyDB

Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach.

Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach.

http://www.wikidata.org/entity/Q33895154

about

Characterization of uncultivable bat influenza virus using a replicative synthetic virus Rotavirus NSP1 inhibits NFkappaB activation by inducing proteasome-dependent degradation of beta-TrCP: a novel mechanism of IFN antagonism Antiviral response in pandemic influenza viruses Making better influenza virus vaccines?Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus Rotavirus nonstructural protein 1 subverts innate immune response by inducing degradation of IFN regulatory factor 3 Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza Viral Inhibition of the IFN-Induced JAK/STAT Signalling Pathway: Development of Live Attenuated Vaccines by Mutation of Viral-Encoded IFN-Antagonists Development of next-generation respiratory virus vaccines through targeted modifications to viral immunomodulatory genes Recent progress in structure-based anti-influenza drug design Capsid Protein of Eastern Equine Encephalitis Virus Inhibits Host Cell Gene Expression Structural basis for suppression of a host antiviral response by influenza A virus Reverse Genetics Approaches for the Development of Influenza Vaccines Influenza: old and new threats Influenza A virus attenuation by codon deoptimization of the NS gene for vaccine development Sublingual immunization with a live attenuated influenza a virus lacking the nonstructural protein 1 induces broad protective immunity in mice A pandemic influenza H1N1 live vaccine based on modified vaccinia Ankara is highly immunogenic and protects mice in active and passive immunizations Plasmid-only rescue of influenza A virus vaccine candidates.Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza Switch from protective to adverse inflammation during influenza: viral determinants and hemostasis are caught as culprits.Host defense mechanism-based rational design of live vaccine Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice Model of influenza A virus infection: dynamics of viral antagonism and innate immune response.Development of a mucosal vaccine for influenza viruses: preparation for a potential influenza pandemic.Functional genomic and serological analysis of the protective immune response resulting from vaccination of macaques with an NS1-truncated influenza virus.Novel approach to the development of effective H5N1 influenza A virus vaccines: use of M2 cytoplasmic tail mutants.Influenza vaccines: a moving interdisciplinary field.Attenuated influenza A viruses with modified cleavage sites in hemagglutinin as live vaccines.Development of a vaccine against pandemic influenza viruses: current status and perspectives.Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine.Several hemagglutinins of same serotype for induction of broad immunity against influenza A virus antigenic drift variants: WO2008048984.NS-based live attenuated H1N1 pandemic vaccines protect mice and ferrets Cross-protective immunity to influenza A viruses.A reassortment-incompetent live attenuated influenza virus vaccine for protection against pandemic virus strains.The influenza virus NS1 protein as a therapeutic target.New strategies for the development of H5N1 subtype influenza vaccines: progress and challenges.Current cell-based influenza vaccine production technology as pandemic contingency.Pseudotyped influenza A virus as a vaccine for the induction of heterotypic immunity Vaccine development for protecting swine against influenza virus.

P2860

Q21089589-CDBA0FB5-B1D9-4EFC-B6EE-7736434EFCC4 Q21090517-F13E23B6-9216-4FF0-ABCB-ADB067D6AAB1 Q22305645-6D5E1E57-918D-4867-BBE6-D1884567128E Q22305647-9226666B-872A-4EB6-882E-DA63A806CEA4 Q24311228-F3394D3D-0B75-4B99-B74A-BB2A34A6A726 Q24555785-D50EB469-D7FF-4E4A-B947-8A17925EEF35 Q24598177-278CB9B8-C1F2-469C-91F1-C27C1308EC7D Q24652088-1881B519-3CF7-4D9D-A648-7B4009699A5A Q26745547-AD1E494D-3E2E-45B8-8BEB-0C02E1E3BB1C Q26782411-10D703BA-FA94-429A-B848-C89FAFFB39ED Q26863710-0242BB32-4D3F-4D51-A423-6B8481045A63 Q27478382-D02E897E-F9D7-4D02-AA2B-ADB29F8473DE Q27651800-86062A38-FEC8-43B1-B8E4-5F9F5C66EECC Q28076140-821AA8AD-2DDB-4863-8864-A6992E8B49AE Q28296381-F0E67EE3-D34B-468F-8159-6329FA919D88 Q28395006-B585C86B-9AE7-4558-B8ED-1ABFE477B965 Q28727930-B25A18B8-4B79-43F5-9A07-2FD1F3C80B0A Q28749671-164AF7B0-7570-4D37-9064-B655084F6D92 Q30329368-3AB50C88-9239-4F2D-9E97-53F67E9E9A08 Q30331304-F64F3230-0627-440B-897C-789A18405CB4 Q30354127-5E24CD39-BD92-46C2-844D-C03FD1D75DB7 Q30354189-527F1CD7-6973-4184-84D8-E1FA31BBD93E Q30355968-2ABE8DDB-6462-4BA7-88A0-6AEAE436C24B Q30359771-2D5E3347-88C5-4F99-A305-CFCADE1FF6DB Q30360869-B9D1265B-7FE9-49A1-AD5C-66A804A36C1E Q30363578-38EBAB3F-0841-42BD-95C3-2263E23A89E6 Q30366819-D85D459B-5022-48C2-89C8-815892478D0A Q30367695-57619382-79C1-4037-840B-E4292D07A71A Q30371054-F6D8E745-F481-4EFB-B0DD-6FC398E0E3B3 Q30373784-78D45058-5281-4A23-ACAD-87ECCF40B95B Q30377447-AA97E85B-BACD-4F83-8B94-BCA933C805E6 Q30385956-6AAEF1BB-959F-4105-B6BA-715DC67B1D48 Q30394706-8FEEA375-ABDD-4F5C-ABE0-FC29A565402B Q30396399-62971254-449D-4BEA-ADFE-01D52299FFEA Q30402334-A928E0BA-00CD-47B2-862F-493BC62A620B Q30407133-4D020F1B-62CC-4042-BD85-C097D72D3AE0 Q30407424-29461D2F-CB53-4D68-901B-A1936B55DBD9 Q30414391-03C6465B-93E2-4A05-8F88-CD1976011160 Q30421682-9195B581-DC8C-4E38-857A-8D0E7150984A Q30424943-748FE56D-EC42-4A87-A826-B2FA13FC5AD0

P2860

Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach.

http://www.wikidata.org/entity/Q33895154

description

2000 nî lūn-bûn

@nan

2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年学术文章

@wuu

2000年学术文章

@zh-cn

2000年学术文章

@zh-hans

2000年学术文章

@zh-my

2000年学术文章

@zh-sg

2000年學術文章

@yue

name

Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach.

@ast

Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach.

@en

type

label

Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach.

@ast

Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach.

@en

prefLabel

Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach.

@ast

Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach.

@en

P1433

Q33895154-C47839CB-9C39-4BE2-8B11-721547BA9526

P1476

Q33895154-4C2692FC-33AC-45F5-A3CE-8FB51A62542C

P2093

Q33895154-1CEAEEC1-F6EE-4D78-A6B7-74D9FCAB9244

Q33895154-305F2485-8C65-4D4B-B470-5909C547F7F4

Q33895154-3935B5D2-570B-40D0-84F4-EA0BF2D87633

Q33895154-404E0727-F3FD-48A4-B9E1-EB4B09CFA188

Q33895154-90B1682C-4550-4802-B148-175523B582C8

Q33895154-9E35B98B-1475-46FE-A2F1-51F22F5CB84B

Q33895154-E9044714-B7B1-4AC0-8073-4017F69F6671

P2860

Q33895154-0254F80F-B624-4D55-85FB-12A6A3BC988B

Q33895154-0BC1894A-102C-4857-B915-1D78E7657412

Q33895154-15615A06-AD06-4FBB-851C-153CA18E2958

Q33895154-1BAC012F-1658-4813-A61D-0FC6472329C2

Q33895154-1BD752E8-42DD-48B0-B037-8D1C65CFDC17

Q33895154-21EBF33C-4974-4861-8F8A-2832D526CA5A

Q33895154-3F2964AA-B205-4883-BAD0-B1553A1B57A6

Q33895154-3FBD5119-54C5-4D44-BD44-D6B560D6A589

Q33895154-46075C10-90A9-4AF2-9AF3-4CC2BF4E0700

Q33895154-4717D82C-25D0-474C-8ED8-F6BC8C466EAA

P304

Q33895154-F68B7D6A-69D5-4231-900A-9BD7975A98F1

P31

Q33895154-315B8E53-997D-42EF-8930-B51306472129

P356

Q33895154-8F0E780A-3389-46BD-9DB6-EE7AC9C1B35F

P407

Q33895154-1693AB62-F676-4440-BEC7-F4FEBBBC751A

P433

Q33895154-52E7FA50-D9BA-4BF4-943C-CD9FC1FCC3A9

P478

Q33895154-E62F1FB1-6A95-4957-8BFB-5CE916E23880

P50

Q33895154-FAD5065A-1276-4F8B-BA0E-08587789C643

P577

Q33895154-65CE4A80-4420-4621-8838-DC000819C1E3

P5875

Q33895154-E4B68EDE-8ED0-4719-B7F8-7B056FB201F6

P698

Q33895154-36B0A4B4-B322-45CF-BB64-A17B3127BAD6

P932

Q33895154-1C988FC3-8387-4407-90BE-E63EBA06797A

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach.

@en

P2093

García-Sastre A

http://www.w3.org/2001/XMLSchema#string

Muster T

http://www.w3.org/2001/XMLSchema#string

Nakaya Y

http://www.w3.org/2001/XMLSchema#string

O'Neill RE

http://www.w3.org/2001/XMLSchema#string

Salvatore M

http://www.w3.org/2001/XMLSchema#string

Talon J

http://www.w3.org/2001/XMLSchema#string

Zheng H

http://www.w3.org/2001/XMLSchema#string

P2860

How cells respond to interferons

Influenza A Virus Lacking the NS1 Gene Replicates in Interferon-Deficient Systems

A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans.

Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines

Sendai virus and simian virus 5 block activation of interferon-responsive genes: importance for virus pathogenesis

Sendai virus C proteins counteract the interferon-mediated induction of an antiviral state

A universal influenza A vaccine based on the extracellular domain of the M2 protein.

The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins

When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA.

Amplification, expression, and packaging of foreign gene by influenza virus.

P304

4309-4314

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.070525997

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P50

P577

2000-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235613108

http://www.w3.org/2001/XMLSchema#string

P698

10725408

http://www.w3.org/2001/XMLSchema#string

P932

18238

http://www.w3.org/2001/XMLSchema#string